基于转录组学的药理学识别了表观遗传和细胞循环调节剂,这些调节剂可以增强AAV的产生

相关实验视频

Updated: Jul 15, 2026

Production of Adeno-Associated Virus Vectors in Cell Stacks for Preclinical Studies in Large Animal Models

Production of Adeno-Associated Virus Vectors in Cell Stacks for Preclinical Studies in Large Animal Models

Published on: June 30, 2021

Joshua Tworig¹, Francis Grafton¹, Kaylin Fisher¹

¹Ascend Advanced Therapies CA, Inc, Alameda, CA 94501, USA.

Molecular therapy. Methods & clinical development

|December 17, 2024

概括

了解复合腺相关病毒 (rAAV) 生产过程中的细胞反应可以改善制造. 这项研究确定了关键的细胞标和药物类别,如基因素脱乙酶和微管抑制剂,以增强用于基因治疗的rAAV载体生产.

科学领域:

分子生物学分子生物学
生物技术是生物技术.
基因治疗基因治疗

背景情况:

再组合腺相关病毒 (rAAV) 载体对于基因疗法至关重要,但面临制造限制.
在rAAV生产中的挑战源于生产率和矢量质量方面的问题.
要克服这些局限性,需要更好地了解RAAV生产过程中的细胞机制.

研究的目的:

为了确定可以增强rAAV生产的细胞目标.
在不同细胞系的rAAV生产过程中分析转录反应.
为了比较高和低rAAV生成细胞的转录特征.

主要方法:

对具有不同rAAV生产能力的五个细胞系进行了转录基因分析.
在rAAV生产过程中测量转录反应的交叉方法.
药物连接性分析,以预测增强rAAV生产的化合物.

主要成果:

细胞周期和核细胞组件的转录差异与增殖能力和DNA复制有关.
观察到转录,应激反应和器官组织的升级 (Golgi, ER).
对DNA结合蛋白抑制剂和线粒体组分的下调.
确定了五种类型的药物,预计可以增强rAAV的产生.
希斯脱乙酶和微管抑制剂在增强生产方面表现出有效性.

结论:

发现了影响rAAV生产和质量的新和已知的途径.
数据表明,特定的细胞通路和药物干预可以改善rAAV制造.
这些发现有助于扩大用于基因治疗的rAAV载体的可用性.

关键词:

在 AAV AAV AAV 中.在RNA测序过程中,RNA测序腺相关病毒的病毒.基因本体学基因本体学基因治疗的基因疗法时间序列分析分析时间序列分析转录组分析转录组分析病毒载体制造病毒载体制造

更多相关视频

Isolation of Next-Generation Gene Therapy Vectors through Engineering, Barcoding, and Screening of Adeno-Associated Virus AAV Capsid Variants

Isolation of Next-Generation Gene Therapy Vectors through Engineering, Barcoding, and Screening of Adeno-Associated Virus AAV Capsid Variants

Published on: October 18, 2022

Author Spotlight: Efficient Adeno-Associated Virus Isolation for Pre-Clinical Applications

Author Spotlight: Efficient Adeno-Associated Virus Isolation for Pre-Clinical Applications

Published on: February 9, 2024

相关概念视频

Regulation of Expression at Multiple Steps

Regulation of Expression at Multiple Steps

The gene expression in cells is regulated at different stages: (i) transcription, (ii) RNA processing, (iii) RNA localization, and (iv) translation. Transcriptional regulation is mediated by regulatory proteins such as transcription factors, activators, or repressors—these control gene expression by initiating or inhibiting the transcription of genes. Once a precursor or pre-mRNA is produced, it undergoes post-transcriptional modification, including 5' capping, splicing, and the addition of a...

Pharmacogenomics: Identification of New Drug Targets

Pharmacogenomics: Identification of New Drug Targets

Advances in genomics have profoundly influenced drug discovery by increasing both the speed and accuracy of pharmaceutical development. Pharmacogenomics, which examines how genetic variation influences drug response, facilitates the identification of novel therapeutic targets and enables patient stratification for personalized treatment. These strategies contribute to improved drug efficacy, minimized adverse effects, and more efficient clinical trial design.Mapping genetic differences...